Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Enlarging scalp mass.
Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats.
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.
Separation of circadian and wake duration-dependent modulation of EEG activation during wakefulness.
Outcome measures for clinical trials in fragile X syndrome.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Outcome measures for clinical trials in fragile X syndrome.
Outcome measures for clinical trials in fragile X syndrome. J Dev Behav Pediatr. 2013 Sep; 34(7):508-22.
View in:
PubMed
subject areas
Child
Clinical Trials as Topic
Cognition
Education
Educational Status
Executive Function
Fragile X Syndrome
Humans
Language
Language Tests
Learning
Memory
Neuropsychological Tests
Treatment Outcome
authors with profiles
Elizabeth M Berry-Kravis